H2CBD, a synthetic version of the cannabis compound CBD, has been found to be effective in decreasing the number and severity of seizures in rats.
CBD reduces craving and anxiety in those with heroin use disorder during withdrawal from the drug. There were no serious adverse reactions, or impairments to cognition noted with the administration of CBD. Researchers suggest cannabidiol may be useful in helping to combat opioid addiction.
Dogs with epilepsy who received cannabidiol as part of a clinical trial had a reduction in the frequency of seizures.
Results from a phase 3 study reveal Cannabidiol (CBD) cuts seizures by almost 50% in children with Dravet syndrome.
Cannabidiol may buffer the effects of THC on the brain for those who use marijuana. Marijuana with a higher CBD content restores disruptions to the salience network caused by THC exposure.
Cannabidiol may be able to bypass the blood-brain barrier to effectively deliver medications directly to the brain.
Classical music exposure paired with ibuprofen reduced response to inflammation pain by 93%, compared to exposure to the medication alone in mouse models of pain. For those exposed to just music, researchers report a 77% reduction in surgical pain.
More than 80% of parents reported significant or moderate improvements in their child's ASD symptoms following medical cannabis treatment, a new study reports.
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems.
Researchers provide the first cannabis chromosome map, revealing ancient viruses contributed to the evolution of marijuana.
A new study reports a 39 to 46% reduction in seizures in children with Dravet syndrome and Lennox-Gastaut syndrome when given CBD based treatments.
Researchers have pinpointed an effective dose of CBD to help treat chronic pain, without generating the typical marijuana 'high'.
